13/10/2026
How toxicophore screening can support non-mutagenic impurity assessment as one line of evidence in a broader weight-of-evidence framework.
How toxicophore screening can support non-mutagenic impurity assessment as one line of evidence in a broader weight-of-evidence framework.
Technical guide to selecting critical effects and points of departure in PDE/HBEL assessments using clinical and non-clinical evidence.
Um dos trabalhos apresentados pela Altox, na forma de pôster, recebeu menção honrosa no XX Congresso Brasileiro de Toxicologia (CBTOX). Este trabalho, tratando do uso